Breast cancer has been the most commonly diagnosed cancer among women worldwide for years running, but GLP-1s may help. The ...

A phase 3 clinical trial has demonstrated that daraxonrasib significantly improved overall survival and progression-free ...

A growing body of evidence suggests that popular GLP-1 drugs, widely used for weight loss and diabetes, can provide ...

Significant reductions seen in non-small cell lung cancer, breast cancer, colorectal cancer, and hepatocellular carcinoma.

Ovarian cancer occurs when there is an uncontrolled growth of abnormal cells in the ovaries or fallopian tubes. This is one ...

A plant-based compound called sulfuretin is being explored as a potential cancer treatment. Sulfuretin stopped the progression of cancer cells in a lab study. Researchers are doing additional testing ...

A novel PET imaging approach enables simultaneous visualization of tumor progression and cardiac inflammatory responses during cancer treatment.

In a phase 3 trial of patients with dedifferentiated liposarcoma, the CDK4/6 inhibitor extended progression-free survival ...

Patients with early-stage bladder cancer are often able to maintain their usual routines. Some may experience urinary ...